je.st
news
Tag: pharma
Pharma industry gets high on profits
2014-11-06 10:00:17| BBC News | Business | UK Edition
How do pharma firms make such fat profits?
Tags: high
industry
profits
pharma
Valeant Pharma Q3 profit beats estimates, company raises outlook for Q4, 2015
2014-10-20 16:06:43| Biotech - Topix.net
Valeant Pharmaceuticals International Inc. beat analyst estimates for third-quarter profit and says both the fourth quarter and 2015 are looking more positive than estimates have forecast. The Montreal-area company reported US$275.4 million of net income, or 82 cents per share, under standard accounting and US$718.8 million after adjustments, resulting in $2.11 per share of adjusted EPS.
Tags: company
profit
estimates
outlook
Epson America to Attend Pharma EXPO
2014-10-10 19:02:00| Packaging Gateway
Epson America is attending Pharma EXPO to address widespread industry challenges and showcase its family of Just In Time Color (JITC) labelling solutions and portfolio ColorWorks technologies.
Tags: america
attend
epson
expo
Salix Pharma scuttles Cosmo Technologies merger
2014-10-03 17:20:28| Biotech - Topix.net
Salix Pharmaceuticals is scrapping its merger with the subsidiary of an Italian drugmaker after the U.S. created new limitations on the tax benefits of incorporating overseas. Shares of the Raleigh, North Carolina, drugmaker jumped almost 6 percent Friday morning before markets opened and after Salix said that a transformed political environment has created more uncertainty about the benefits they had expected to achieve from the deal, first announced in July.
Tags: technologies
merger
pharma
cosmo
Valeant Pharma expects 3Q revenue to top forecasts
2014-09-25 00:03:23| Biotech - Topix.net
Shares of Valeant Pharmaceuticals International Inc. climbed Wednesday after the Canadian drugmaker said it expects market share gains in most of its businesses and that its third-quarter revenue will top forecasts. The drugmaker also said it expects 10 percent growth from the established business of its contact lens maker Bausch + Lomb, a target of criticism in Valeant's on-going takeover battle with Botox-maker Allergan Inc. Allergan has rebuffed several takeover bids from Valeant over the past few months, the latest amounting to about $53 billion.
Tags: top
revenue
expects
forecasts
Sites : [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] next »